NCT01518634View on ClinicalTrials.gov

Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome

PHASE2CompletedINTERVENTIONAL

Enrollment

138

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2016

Conditions

Somatisation DisorderSomatoform Disorders

Interventions

DRUG

Imipramine treatment

Two-week of wash-out, one week of 10 mg study drug, 10 weeks of 25-75 mg study drug, four weeks of phasing-out and finaly two weeks after ther last dose of study drug to monito adverse events.

DRUG

Placebo

Two-week of wash-out, one week of 10 mg study drug, 10 weeks of 25-75 mg study drug, four weeks of phasing-out and finaly two weeks after ther last dose of study drug to monito adverse events.

Trial Locations (1)

8000

Research Clinic for Functional Disorders, Aarhus

All Listed Sponsors

lead

University of Aarhus

OTHER

NCT01518634 - Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome | Biotech Hunter | Biotech Hunter